 | • レポートコード：MRC2-11QY03837 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は分子診断・NATのグローバル市場について調査・分析したレポートです。種類別（増幅技術、増幅遺伝子検出技術、DNA・オリゴヌクレオチドマイクロアレイ、遺伝子シークエンシング）市場規模、用途別（病院・診療所、研究所、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別分子診断・NATの競争状況、市場シェア ・世界の分子診断・NAT市場：種類別市場規模 2015年-2020年（増幅技術、増幅遺伝子検出技術、DNA・オリゴヌクレオチドマイクロアレイ、遺伝子シークエンシング） ・世界の分子診断・NAT市場：種類別市場規模予測 2021年-2026年（増幅技術、増幅遺伝子検出技術、DNA・オリゴヌクレオチドマイクロアレイ、遺伝子シークエンシング） ・世界の分子診断・NAT市場：用途別市場規模 2015年-2020年（病院・診療所、研究所、診断センター） ・世界の分子診断・NAT市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究所、診断センター） ・北米の分子診断・NAT市場分析：米国、カナダ ・ヨーロッパの分子診断・NAT市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの分子診断・NAT市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の分子診断・NAT市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの分子診断・NAT市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Abbott、BD、Biomerieux、Qiagen、Thermo Fisher Scientific、Agilent、GenMark、Siemens Healthcare、AutoGenomics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
Market Analysis and Insights: Global Molecular Diagnostics and NAT Market
The global Molecular Diagnostics and NAT market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Molecular Diagnostics and NAT Scope and Market Size
Molecular Diagnostics and NAT market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics and NAT market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Market segment by Type, the product can be split into
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Market segment by Application, split into
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Molecular Diagnostics and NAT Revenue
1.4 Market by Type
1.4.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Amplification Technologies
1.4.3 Amplified Gene Detection Technologies
1.4.4 DNA And Oligonucleotide Microarrays
1.4.5 Gene Sequencing
1.5 Market by Application
1.5.1 Global Molecular Diagnostics and NAT Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research Institutes
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics and NAT Market Perspective (2015-2026)
2.2 Global Molecular Diagnostics and NAT Growth Trends by Regions
2.2.1 Molecular Diagnostics and NAT Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Molecular Diagnostics and NAT Historic Market Share by Regions (2015-2020)
2.2.3 Molecular Diagnostics and NAT Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Molecular Diagnostics and NAT Market Growth Strategy
2.3.6 Primary Interviews with Key Molecular Diagnostics and NAT Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics and NAT Players by Market Size
3.1.1 Global Top Molecular Diagnostics and NAT Players by Revenue (2015-2020)
3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Players (2015-2020)
3.1.3 Global Molecular Diagnostics and NAT Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Molecular Diagnostics and NAT Market Concentration Ratio
3.2.1 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics and NAT Revenue in 2019
3.3 Molecular Diagnostics and NAT Key Players Head office and Area Served
3.4 Key Players Molecular Diagnostics and NAT Product Solution and Service
3.5 Date of Enter into Molecular Diagnostics and NAT Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2015-2020)
4.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Molecular Diagnostics and NAT Market Size by Application (2015-2020)
5.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Molecular Diagnostics and NAT Market Size (2015-2020)
6.2 Molecular Diagnostics and NAT Key Players in North America (2019-2020)
6.3 North America Molecular Diagnostics and NAT Market Size by Type (2015-2020)
6.4 North America Molecular Diagnostics and NAT Market Size by Application (2015-2020)
7 Europe
7.1 Europe Molecular Diagnostics and NAT Market Size (2015-2020)
7.2 Molecular Diagnostics and NAT Key Players in Europe (2019-2020)
7.3 Europe Molecular Diagnostics and NAT Market Size by Type (2015-2020)
7.4 Europe Molecular Diagnostics and NAT Market Size by Application (2015-2020)
8 China
8.1 China Molecular Diagnostics and NAT Market Size (2015-2020)
8.2 Molecular Diagnostics and NAT Key Players in China (2019-2020)
8.3 China Molecular Diagnostics and NAT Market Size by Type (2015-2020)
8.4 China Molecular Diagnostics and NAT Market Size by Application (2015-2020)
9 Japan
9.1 Japan Molecular Diagnostics and NAT Market Size (2015-2020)
9.2 Molecular Diagnostics and NAT Key Players in Japan (2019-2020)
9.3 Japan Molecular Diagnostics and NAT Market Size by Type (2015-2020)
9.4 Japan Molecular Diagnostics and NAT Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Molecular Diagnostics and NAT Market Size (2015-2020)
10.2 Molecular Diagnostics and NAT Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2015-2020)
10.4 Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2015-2020)
11 India
11.1 India Molecular Diagnostics and NAT Market Size (2015-2020)
11.2 Molecular Diagnostics and NAT Key Players in India (2019-2020)
11.3 India Molecular Diagnostics and NAT Market Size by Type (2015-2020)
11.4 India Molecular Diagnostics and NAT Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Molecular Diagnostics and NAT Market Size (2015-2020)
12.2 Molecular Diagnostics and NAT Key Players in Central & South America (2019-2020)
12.3 Central & South America Molecular Diagnostics and NAT Market Size by Type (2015-2020)
12.4 Central & South America Molecular Diagnostics and NAT Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Molecular Diagnostics and NAT Introduction
13.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Molecular Diagnostics and NAT Introduction
13.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 BD
13.3.1 BD Company Details
13.3.2 BD Business Overview
13.3.3 BD Molecular Diagnostics and NAT Introduction
13.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.3.5 BD Recent Development
13.4 Biomerieux
13.4.1 Biomerieux Company Details
13.4.2 Biomerieux Business Overview
13.4.3 Biomerieux Molecular Diagnostics and NAT Introduction
13.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.4.5 Biomerieux Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Molecular Diagnostics and NAT Introduction
13.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Details
13.6.2 Thermo Fisher Scientific Business Overview
13.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Introduction
13.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.6.5 Thermo Fisher Scientific Recent Development
13.7 Agilent
13.7.1 Agilent Company Details
13.7.2 Agilent Business Overview
13.7.3 Agilent Molecular Diagnostics and NAT Introduction
13.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.7.5 Agilent Recent Development
13.8 GenMark
13.8.1 GenMark Company Details
13.8.2 GenMark Business Overview
13.8.3 GenMark Molecular Diagnostics and NAT Introduction
13.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.8.5 GenMark Recent Development
13.9 Siemens Healthcare
13.9.1 Siemens Healthcare Company Details
13.9.2 Siemens Healthcare Business Overview
13.9.3 Siemens Healthcare Molecular Diagnostics and NAT Introduction
13.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.9.5 Siemens Healthcare Recent Development
13.10 AutoGenomics
13.10.1 AutoGenomics Company Details
13.10.2 AutoGenomics Business Overview
13.10.3 AutoGenomics Molecular Diagnostics and NAT Introduction
13.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2015-2020)
13.10.5 AutoGenomics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Molecular Diagnostics and NAT Key Market Segments
Table 2. Key Players Covered: Ranking by Molecular Diagnostics and NAT Revenue
Table 3. Ranking of Global Top Molecular Diagnostics and NAT Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Amplification Technologies
Table 6. Key Players of Amplified Gene Detection Technologies
Table 7. Key Players of DNA And Oligonucleotide Microarrays
Table 8. Key Players of Gene Sequencing
Table 9. Global Molecular Diagnostics and NAT Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Molecular Diagnostics and NAT Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Molecular Diagnostics and NAT Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Molecular Diagnostics and NAT Market Share by Regions (2015-2020)
Table 13. Global Molecular Diagnostics and NAT Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Molecular Diagnostics and NAT Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Molecular Diagnostics and NAT Market Growth Strategy
Table 19. Main Points Interviewed from Key Molecular Diagnostics and NAT Players
Table 20. Global Molecular Diagnostics and NAT Revenue by Players (2015-2020) (Million US$)
Table 21. Global Molecular Diagnostics and NAT Market Share by Players (2015-2020)
Table 22. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics and NAT as of 2019)
Table 23. Global Molecular Diagnostics and NAT by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Molecular Diagnostics and NAT Product Solution and Service
Table 26. Date of Enter into Molecular Diagnostics and NAT Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 29. Global Molecular Diagnostics and NAT Market Size Share by Type (2015-2020)
Table 30. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2021-2026)
Table 31. Global Molecular Diagnostics and NAT Market Size Share by Application (2015-2020)
Table 32. Global Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 33. Global Molecular Diagnostics and NAT Market Size Share by Application (2021-2026)
Table 34. North America Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 36. North America Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 37. North America Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 38. North America Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 39. North America Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 40. Europe Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 42. Europe Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 44. Europe Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 46. China Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 47. China Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 48. China Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 49. China Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 50. China Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 51. China Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 52. Japan Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 54. Japan Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 56. Japan Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 60. Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 62. Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 64. India Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 65. India Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 66. India Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 67. India Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 68. India Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 69. India Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Molecular Diagnostics and NAT Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Molecular Diagnostics and NAT Market Share (2019-2020)
Table 72. Central & South America Molecular Diagnostics and NAT Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Molecular Diagnostics and NAT Market Share by Type (2015-2020)
Table 74. Central & South America Molecular Diagnostics and NAT Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Molecular Diagnostics and NAT Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Product
Table 84. Abbott Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 85. Abbott Recent Development
Table 86. BD Company Details
Table 87. BD Business Overview
Table 88. BD Product
Table 89. BD Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 90. BD Recent Development
Table 91. Biomerieux Company Details
Table 92. Biomerieux Business Overview
Table 93. Biomerieux Product
Table 94. Biomerieux Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 95. Biomerieux Recent Development
Table 96. Qiagen Company Details
Table 97. Qiagen Business Overview
Table 98. Qiagen Product
Table 99. Qiagen Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 100. Qiagen Recent Development
Table 101. Thermo Fisher Scientific Company Details
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Product
Table 104. Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 105. Thermo Fisher Scientific Recent Development
Table 106. Agilent Company Details
Table 107. Agilent Business Overview
Table 108. Agilent Product
Table 109. Agilent Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 110. Agilent Recent Development
Table 111. GenMark Business Overview
Table 112. GenMark Product
Table 113. GenMark Company Details
Table 114. GenMark Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 115. GenMark Recent Development
Table 116. Siemens Healthcare Company Details
Table 117. Siemens Healthcare Business Overview
Table 118. Siemens Healthcare Product
Table 119. Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 120. Siemens Healthcare Recent Development
Table 121. AutoGenomics Company Details
Table 122. AutoGenomics Business Overview
Table 123. AutoGenomics Product
Table 124. AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2015-2020) (Million US$)
Table 125. AutoGenomics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics and NAT Market Share by Type: 2020 VS 2026
Figure 2. Amplification Technologies Features
Figure 3. Amplified Gene Detection Technologies Features
Figure 4. DNA And Oligonucleotide Microarrays Features
Figure 5. Gene Sequencing Features
Figure 6. Global Molecular Diagnostics and NAT Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Molecular Diagnostics and NAT Report Years Considered
Figure 11. Global Molecular Diagnostics and NAT Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Molecular Diagnostics and NAT Market Share by Regions: 2020 VS 2026
Figure 13. Global Molecular Diagnostics and NAT Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Molecular Diagnostics and NAT Market Share by Players in 2019
Figure 16. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics and NAT as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnostics and NAT Revenue in 2019
Figure 18. North America Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Molecular Diagnostics and NAT Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …- 分子診断の世界市場（～2026年） Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule duri…
- 獣医分子診断の世界市場（～2026年） The molecular diagnostic is defined as a technique for used in the laboratory for to identify a disease or its predisposition stage by analyzing the DNA or RNA or other proteins in humans and animals. Rising prevalence of various animal diseases globally is expected to favor the veterinary molecular…
- POC分子診断の世界市場（～2026年） Market Analysis and Insights: Global POC Molecular Diagnostics Market The global POC Molecular Diagnostics market size is projected to reach US$ 654.1 million by 2026, from US$ 580.4 million in 2020, at a CAGR of 11.8%% during 2021-2026. Global POC Molecular Diagnostics Scope and Market Size POC Mol…
- ウイルス分子診断の世界市場（～2026年） Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastru…